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Abstract
Background: Several platforms for the analysis of genome-wide association data are available. However, these
platforms focus on the evaluation of the genotype inherited by affected (i.e. case) individuals, whereas for some
conditions (e.g. birth defects) the genotype of the mothers of affected individuals may also contribute to risk. For
such conditions, it is critical to evaluate associations with both the maternal and the inherited (i.e. case) genotype.
When genotype data are available for case-parent triads, a likelihood-based approach using log-linear modeling
can be used to assess both the maternal and inherited genotypes. However, available software packages for log-
linear analyses are not well suited to the analysis of typical genome-wide association data (e.g. including missing
data).
Results: An integrated platform, Maternal and Inherited Analyses for Genome-wide Association Studies (MI-GWAS)
for log-linear analyses of maternal and inherited genetic effects in large, genome-wide datasets, is described. MI-
GWAS uses SAS and LEM software in combination to appropriately format data, perform the log-linear analyses
and summarize the results. This platform was evaluated using existing genome-wide data and was shown to
perform accurately and relatively efficiently.
Conclusions: The MI-GWAS platform provides a valuable tool for the analysis of association of a phenotype or
condition with maternal and inherited genotypes using genome-wide data from case-parent triads. The source
code for this platform is freely available at http://www.sph.uth.tmc.edu/sbrr/mi-gwas.htm.
Background
Candidate gene, and more recently, genome-wide asso-
ciation (GWA) studies have been used to identify asso-
ciations between several complex diseases and the
genotype of affected individuals (i.e. cases) [1-6]. How-
ever, for some phenotypes (e.g. birth defects, perinatal
outcomes, pediatric cancers), the maternal genotype
may also directly contribute to risk, via an effect on the
in utero environment [7]. However, despite increasing
recognition of the importance of maternal genetic
effects in genetic epidemiology studies [8-17], nearly all
GWA studies to date have ignored maternal genetic
effects [18], which could partially explain why GWA
studies have not identified the majority of the genetic
contribution to common diseases. Failure to account for
maternal genetic effects in previous studies may be due
both to lack of appropriate data (i.e. maternal DNA is
not collected in traditional case-control studies) and
lack of a readily available platform for performing ana-
lyses that account for maternal genetic effects using
typical GWA data.
The most common study designs used in GWA stu-
dies include the case-control and case-parent triad
designs. Though the case-control approach has been
used more frequently, distinguishing between maternal
and inherited genetic effects using this study design
requires the addition of samples from mothers of both
cases and controls, resulting in increased genotyping
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lected for most existing case-control studies. By con-
trast, maternal genetic effects can be directly assessed in
existing data from case-parent triad GWA studies. How-
ever, in the majority of these studies, data have been
analyzed using the transmission disequilibrium test
(TDT) [19,20], which does not assess maternal genetic
effects.
The most commonly used method for assessing mater-
nal and inherited genetic effects using case-parent triad
data is a log-linear, likelihood-based approach [21,22]. In
addition to evaluating maternal genetic effects, this
approach has the advantage (over the TDT) of providing
estimates of effect size and, similar to the TDT, does not
require the assumption of Hardy-Weinberg equilibrium
[21-24]. Further, using this approach, data from incom-
plete triads can be included in the analysis by use of the
expectation-maximization (EM) algorithm [23]. These
log-linear analyses can be conducted using standard soft-
ware (e.g. SAS
®, SAS Institute Inc.), but, when data from
incomplete triads are included, require programming of
the EM, which is cumbersome. The specialized program,
LEM [25,26], can also be used to conduct these analyses,
and has the advantage over other programs (e.g. SAS) in
that it does not require programming of the EM and can
be easily programmed to explore a variety of additional
types of effects (e.g., gene-gene interaction, gene-environ-
ment interaction). However, because LEM requires indi-
vidual data and program files for each SNP, it is not
feasible to conduct a GWA study analysis using LEM as a
stand-alone program.
To address the need for an efficient approach for ana-
lyzing maternal and inherited genetic effects using
GWA data from case-parent triad studies, a novel com-
putational platform was created. This platform uses SAS
to prepare the data in an LEM-compatible format, calls
LEM to evaluate each SNP, and extracts and sum-
marizes relevant data from the LEM output files. The
performance of this platform was evaluated using exist-
ing, case-parent triad GWA data.
Implementation
Log-linear Modeling
The theoretical distribution (assuming Mendelian
inheritance and mating symmetry) of case-parent triad
genotype data (defined by the combination of father,
mother, and child genotypes) can be fitted to the
observed triad counts by maximum likelihood using the
following log-linear model:
ln[E(nF,M,C)] = γj+β1I(C=1)+β2I(C=2)+α1I(M=1)+α2I(M=2)+ln(wF,M,C) (Model 1)
The values of E(nF,M,C) correspond to the expected
count of each genotype combination (i.e., father, mother,
and child genotypes). The gj term stratifies on parental
mating type (i.e., each combination of possible parental
genotypes), and I is an indicator variable that equals 0,
1, or 2, corresponding to the number of high-risk alleles
present in the child’so rm o t h e r ’sg e n o t y p e( Ca n dM
respectively). The offset, wF,M,C, accounts for the hetero-
zygous genotype being twice as likely as either homozy-
gous genotype in offspring of double heterozygous
matings (assuming Mendelian transmission). Under this
model, the risk corresponding to a genotype with one
copy of the “high-risk” allele compared to no copies can
be estimated by exp(b1) for the inherited genotype and
exp(a1) for the maternal genotype, and the risk corre-
sponding to a genotype with two copies compared to no
copies can be estimated by exp(b2) for the inherited
genotype and exp(a2) for the maternal genotype. The
significance of the inherited genetic effect can be evalu-
ated using a two degree of freedom likelihood ratio test
(LRT) to compare the log-likelihood of the full model (i.
e. Model 1) to that of a reduced model in which b1 = b2
= 0. The null hypothesis for this test is that conditional
on parental mating type, the distribution of affected off-
spring agrees with Mendelian expectation. Similar to the
TDT, this LRT provides a test of linkage in the presence
of linkage disequilibrium that is not vulnerable to con-
founding due to population stratification [21,27]. Like-
wise, the significance of the maternal genetic effect can
be evaluated by using the LRT to compare the log-likeli-
hood of the full model to that of a reduced model in
which a1 = a2 = 0. The null hypothesis for this test is
that reciprocal parental mating types (e.g. Aa × AA and
AA × Aa) occur at the same frequency among parents
of affected individuals [21-23]. This LRT is vulnerable to
a specific form of population stratification that violates
the underlying assumption of mating symmetry. Mating
asymmetry occurs when reciprocal mating types for a
given allele do not occur with equal frequency in the
population (e.g. Aa × AA > AA × Aa). The potential for
this type of bias can be limited by restricting analyses to
matings from the same race and ethnicity [7]. Data from
incomplete triads can also be included in these analyses
by use of the EM algorithm.
Model 1 is a general (i.e. unrestricted) model, in which
no constraints are placed on the relationships between
alleles (i.e. no constraints on b1 and b2 or a1 and a2).
However, in some circumstances power can be
increased by imposing constraints on the general model.
For example, a linear constraint can be imposed upon
the full model for the genetic effect being tested, leaving
the terms for the other genetic effect unconstrained.
This allows for a one degree of freedom LRT. The use
of a linear constraint has been shown to perform well
under a variety of circumstances [7,21-23,28].
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The log-linear modeling approach with EM can be imple-
mented using the LEM program, which can be downloaded
at: http://spitswww.uvt.nl/~vermunt/#Software. LEM
requires individual data and program files for each associa-
tion test. Thus, for each SNP, it requires one data file and
four program files: one for the full model with a linear con-
straint imposed for inherited effects, one for the full model
with a linear constraint imposed for maternal effects, one
for the reduced model to test for inherited effects, and one
for the reduced model to test for maternal effects. Further,
LEM data files must be formatted so that each row contains
genotypes for the three members of the triad, whereas it is
common for genome-wide genotype data to be outputted
as a single file with one individual per row and one allele
per column (e.g. PLINK [29] format) (Table 1).
Maternal and Inherited Analyses for Genome-wide
Association Studies (MI-GWAS)
SAS version 9.2 was used to develop a platform for the
efficient analysis of maternal and inherited genetic
effects in GWA data, using LEM to apply the log-linear
modeling likelihood-based approach. This platform is
called Maternal and Inherited Analyses for Genome-
wide Association Studies (MI-GWAS) and is freely avail-
able at http://www.sph.uth.tmc.edu/sbrr/mi-gwas.htm.
Briefly, MI-GWAS:
1. Reads data from a single PLINK ped file that con-
tains a separate row of data for each triad member.
Each row contains all genotype data for a single
individual, and each genotype is coded as two alleles
(i.e. two columns of data per genotype). By default,
MI-GWAS treats the allele coded as “2” under the
Illumina 1/2 allele coding system as the high-risk
allele.
2. Converts the PLINK data into one LEM data file
per SNP, with a single row of genotype data for each
triad, with genotypes in the order of mother, father,
and child. These genotypes are coded as 0, 1, or 2,
for number of high-risk alleles present (i.e. one col-
umn of data per genotype).
3. Creates LEM program files for each SNP - one
program file per model.
4. Calls LEM to run the relevant analyses (i.e. full
and reduced models) for each SNP.
5. Extracts relevant output (i.e. log-likelihood values,
relative risks and corresponding standard errors)
from LEM.
6. Calculates relevant LRTs and associated p-values.
7. Computes 95% confidence intervals (CIs) for all
relative risks.
8. Merges results with the PLINK marker map file,
which includes chromosome number and rs number
for each SNP.
Table 1 Comparison of PLINK (A) and LEM (B) data format and example data for three hypothetical case-parent triads
(A)
PLINK Genotype Data for 5 SNPs
Family Number Individual ID Paternal ID Maternal ID Sex
a Phenotype
b SNP 1
c SNP 2
c SNP 3
c SNP 4
c SNP 5
c
1001 1001-A 1001-C 1001-B 1 1 1 1 0 0111112
1001 1001-B 0 0 2 0 1 1 1 1121111
1001 1001-C 0 0 1 0 1 1 1 2111100
1002 1002-A 1002-C 1002-B 2 1 0 0 2 2121112
1002 1002-B 0 0 2 0 2 2 1 2001111
1002 1002-C 0 0 1 0 1 1 2 2111222
1003 1003-A 0 1003-B 2 1 1 2 1 2111111
1003 1003-B 0 0 2 0 1 1 1 2110011
(B)
LEM Data File for SNP 1
Mother’s Genotype
d Father’s Genotype
d Case’s Genotype
d
11 1
31 0
10 2
a 1 = male, 2 = female
b 1 = unaffected, 2 = affected
c 0 = allele missing, 1 = allele 1, 2 = allele 2
d 0 = genotype missing, 1 = no high-risk alleles present, 2 = one high-risk alleles present, 3 = two high-risk alleles present
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the inherited and maternal genotype, and outputs
two corresponding data files.
10. Sorts results by relative risk estimates, separately
for the inherited and maternal genotype, and outputs
two corresponding data files.
To increase computation efficiency, repeating sections
of code (i.e. macros) are used to split these steps into
consecutive blocks that process subsets of SNPs (by
default 1,000). Each consecutive subset of SNPs is pro-
cessed separately, and after processing of the last subset
is complete, all results are merged. A visual overview of
the structure of these steps of the platform is provided
in Figure 1.
The use of SAS, a popular statistical software package,
allows for flexibility in the MI-GWAS platform with
simple programming changes. For example, the user can
specify a range of successive SNPs to analyze rather
than running all SNPs at once. This allows the user to
split the analysis between multiple runs or between mul-
tiple computers. The program also includes code that
can be modified to allow the user to specify specific
individuals, triads, or SNPs to be excluded from the ana-
lysis. Further, the log-linear models can be modified to
accommodate other family-based association designs (e.
g. study designs that incorporate grandparents’
genotypes [7]), other relationships between alleles (e.g.
dominant inheritance), and to include other effects such
as gene-gene and gene-environment interactions and
parent of origin effects. By default, a linear constraint is
imposed for the effect that is being tested (e.g. inherited
genotype) and no constraint is imposed for the other
effect (e.g. maternal genotype). The platform can also
process imputed data that has been converted to PLINK
format. Though by default MI-GWAS processes PLINK-
formatted genotype data with Illumina 1/2-based allele
coding, the SAS code can be modified to process geno-
type data that are in other formats.
Evaluation
To validate the MI-GWAS platform and evaluate its
performance, it was used to analyze a large, unpublished
GWA study dataset derived from case-parent triads
ascertained through cases with a conotruncal heart
defect. The subject recruitment methods for this study
have been previously described [17]. Briefly, case-parent
triads were recruited through the Cardiac Center at the
Children’s Hospital of Philadelphia (CHOP) from 1997-
2007 and all participants provided informed consent
under a protocol approved by the Institutional Review
Boards for the Protection of Human Subjects. Cases had
a nonsyndromic, classic conotruncal defect (i.e. tetalogy
of Fallot, D-transposition of the great arteries, double
Figure 1 Summary of MI-GWAS platform structure, displaying steps preformed on subsets of 1,000 SNPs at a time.
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aortic arch) or a related malformation (i.e. perimembra-
nous or posterior malalignment type ventricular septal
defect or an isolated aortic arch anomaly). The genotype
data were generated from blood or saliva samples using
the Illumina HumanHap550 or Human610-Quad Bead-
Chip Platforms at the Center for Applied Genomics at
CHOP. Only SNPs present on both platforms were
analyzed.
To verify MI-GWAS results for inherited genetic
effects using the CHOP dataset, selected SNPs were eval-
uated for complete triads using both PLINK and MI-
GWAS and the chi-square values for the TDT and LRT,
respectively, were compared. (The TDT approach under
PLINK cannot assess maternal genetic effects and does
not incorporate data from incomplete triads into evalua-
tions of inherited genetic effects.) To verify MI-GWAS
results for maternal genetic effects using this dataset,
selected SNPs were evaluated using both MI-GWAS and
LEM run outside of MI-GWAS, and the resulting LRT p-
values were compared. In addition, MI-GWAS was used
to replicate the findings of a candidate gene study con-
ducted in this study population, using LEM run outside
o fM I - G W A S[ 1 7 ] .T ob ec o n s i s t e n tw i t ht h ep r e v i o u s
analyses, MI-GWAS was modified to use an unrestricted
model of inheritance for both genotypes (i.e. a two degree
of freedom LRT), for the latter analysis.
Results
The evaluation dataset included data on 530,350 SNPs
from 837 case-parent triads (497 complete triads and
340 triads with one or two members missing). To con-
firm MI-GWAS results for the test of inherited genetic
effect, MI-GWAS was used to analyze all SNPs in the
subset of complete triads, and chi-square values for the
LRT were compared to TDT chi-square values obtained
using PLINK to analyze the same data. The chi-square
values for the LRTs of inherited genetic effects gener-
ated by MI-GWAS were quite similar to the TDT chi-
square values generated using PLINK (Table 2). There
were subtle differences in the chi-square values for
some of the most significant SNPs, likely due to differ-
ences between the two platforms in rounding and/or
how numbers are stored (e.g., floating point representa-
tion). In addition, identical results were obtained when
program and data files generated by MI-GWAS were
analyzed using the MI-GWAS platform and LEM run
outside of MI-GWAS (data not shown). Finally, the
results for maternal and inherited genetic effects from a
previously published candidate gene study from the
same study population [17] were replicated using MI-
GWAS (data not shown).
As expected, MI-GWAS running times were some-
what faster on computers with better specifications. For
the same 60,000 SNPs, running times ranged from 11
hours 35 minutes to 22 hours 48 minutes for four com-
puters with differing specifications (Table 3).
Discussion
Computational platforms that can evaluate maternal as
well as inherited genetic effects in genome-wide data
from case-parent triads have not been previously
described. By automating the implementation of such
analyses, MI-GWAS provides such a platform. Compari-
son of results from MI-GWAS and LEM run outside of
MI-GWAS, as well as results from MI-GWAS and
PLINK, indicate that this platform performs as intended.
Further, MI-GWAS performs relatively efficiently. From
Table 2 Comparison of chi-square values from the PLINK
TDT and MI-GWAS LRT for inherited genetic effects for a
randomly selected set of SNPs on chromosome one and
most significant autosomal SNPs
SNP PLINK TDT
chi-square
value
MI-GWAS log-linear
modeling chi-square
value
Percent
Difference
a
Chromosome 1
SNPs
SNP 1 0.02 0.02 0.00
SNP 2 2.22 2.22 0.00
SNP 3 0.91 0.91 0.00
SNP 4 0.09 0.09 0.00
SNP 5 0.24 0.24 0.00
SNP 6 1.58 1.58 0.00
SNP 7 2.97 2.98 0.00
SNP 8 1.22 1.22 0.00
Most significant
autosomal
SNPs
SNP 9 22.34 24.06 0.08
SNP 10 22.29 22.57 0.01
SNP 11 21.48 21.64 0.01
SNP 12 20.78 21.02 0.01
SNP 13 19.56 19.77 0.01
a Absolute difference between PLINK chi-square value and MI-GWAS chi-
square value divided by PLINK chi-square value
Table 3 Running times for the analysis of the same
60,000 SNPs using MI-GWAS on four computers with
differing specifications
Machine specifications Running Time
Intel Core 2 Quad CPU Q9550, 2.83 GHz, 3.21 Gb of
RAM
11 hours 35
minutes
Pentium 4 CPU, 3.00 GHz, 2.00 Gb of RAM 20 hours 52
minutes
Pentium D CPU, 3.20 GHz, 1.99 Gb of RAM 21 hours 24
minutes
Intel Xeon CPU E5540, 2.53 GHz, 6.00 Gb of RAM 22 hours 48
minutes
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that on a single average modern consumer computer, it
m a yt a k ea p p r o x i m a t e l yo n ew e e kt or u naG W As t u d y
analysis of ~500,000 SNPs using MI-GWAS. Such an
analysis may run overnight if split between around eight
average consumer computers.
The MI-GWAS platform has the advantage of using
readily available software (i.e. SAS and LEM) and read-
ing a common GWA data input format (i.e. PLINK for-
mat). Further, unlike the TDT approach under PLINK,
analysis under MI-GWAS uses a log-linear approach
that provides estimates of effect size, allows use of data
from incomplete triads [21-23], and, most importantly,
allows estimation of the significance of maternal effects
in addition to inherited effects.
Conclusions
For some conditions, maternal genetic effects may
influence the risk of disease in offspring via an effect
on the in utero environment. However, maternal
genetic effects have not been widely evaluated in GWA
studies, at least partially due to lack of a platform
designed to analyze maternal genetic effects using
GWA data from case-parent triads. The application of
the MI-GWAS platform to GWA analyses expands the
types of genetic effects that can be evaluated with triad
GWA data, which may lead to new insights regarding
the etiology of common diseases. Future developments
of the MI-GWAS platform will involve improving the
efficiency of the platform, and incorporating analyses
of additional types of effects (e.g. parental imprinting,
interactions).
Availability and Requirements
Project name: MI-GWAS (Maternal and Inherited Ana-
lyses for Genome-wide Association Studies)
Project home page: http://www.sph.uth.tmc.edu/sbrr/
mi-gwas.htm
Operating system(s): Platform independent
Programming language: SAS
®
Other requirements: SAS
® release 9.2, LEM release 1.0
(freely available at http://spitswww.uvt.nl/~vermunt/
#Software)
Licence: None for MI-GWAS
Any restrictions to use by non-academics: None for
MI-GWAS
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